• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
CONCLUSIONS: The immunogenicity of two-dose and three-dose HPV vaccine schedules, measured using antibody responses in young females, is comparable. The quadrivalent vaccine probably reduces external genital lesions and anogenital warts in males compared with control. The nonavalent and quadrivalent vaccines offer similar protection against a combined outcome of cervical, vaginal, and vulval precancer lesions or cancer. In people living with HIV, both the bivalent and quadrivalent HPV vaccines result in high antibody responses. For all comparisons of alternative HPV vaccine schedules, the certainty of the body of evidence ...
Source: Cochrane Database of Systematic Reviews - November 21, 2019 Category: General Medicine Authors: Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N Tags: Cochrane Database Syst Rev Source Type: research

Complete remission of relapsed cervical cancer through immunochemoradiotherapy: Two case reports and three proposed mechanism
Conclusion We reported two patients with cervical cancer recurrence after conventional therapy. We combined CCRT and ICRT to augment the host cells' immunosurveillance and reach durable response more than 5 years mimic long-term progression-free survival. These two patients showed promising results.
Source: Gynecology and Minimally Invasive Therapy - April 8, 2016 Category: OBGYN Source Type: research

The FDA Approves a New HPV Vaccine Containing Over Twice as Much Aluminum As its Predecessor
According to recent reports, the FDA has approved yet another HPV vaccine, despite documented safety issues and the new vaccine containing an exceptionally high level of aluminum, a known neurotoxin. Until now, only two vaccines have been manufactured to protect men and women against human papillomavirus (HPV), a virus believed to be the leading cause of cervical cancer: Cervarix, which is believed to protect against strains 16 and 18 of the virus, and Gardasil, which is believed to protect against strains 6, 11, 16 and 18.   //   A Third HPV Vaccine Hits the Market In December 2014, Gardasil 9 vaccine, manu...
Source: vactruth.com - February 1, 2015 Category: Allergy & Immunology Authors: Christina England Tags: Christina England Physical Top Stories aluminum hydroxide Food and Drug Administration (FDA) Gardasil 9 HPV Vaccine Merck Sharp and Dohme Source Type: blogs